Gene: CYP24A1
Official Full Name: cytochrome P450 family 24 subfamily A member 1provided by HGNC
Gene Summary: This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This mitochondrial protein initiates the degradation of 1,25-dihydroxyvitamin D3, the physiologically active form of vitamin D3, by hydroxylation of the side chain. In regulating the level of vitamin D3, this enzyme plays a role in calcium homeostasis and the vitamin D endocrine system. Alternatively spliced transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2008]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO02822 | CYP24A1 Knockout cell line (HeLa) | Human | CYP24A1 | 1:3~1:6 | Negative | Online Inquiry |
KO02823 | CYP24A1 Knockout cell line (HCT 116) | Human | CYP24A1 | 1:2~1:4 | Negative | Online Inquiry |
KO02824 | CYP24A1 Knockout cell line (A549) | Human | CYP24A1 | 1:3~1:4 | Negative | Online Inquiry |
CYP24A1 Gene Knockout Cell Lines are specialized cell lines engineered to lack the expression of the CYP24A1 gene, which encodes for the cytochrome P450 enzyme responsible for inactivating vitamin D metabolites. These cell lines serve as critical tools in investigating the physiological roles of vitamin D and understanding its metabolism, particularly in the context of various diseases. By removing the CYP24A1 gene, researchers can explore the effects of elevated levels of active vitamin D metabolites, providing insights into cellular responses and signaling pathways impacted by vitamin D.
The key function of these knockout cell lines is to facilitate the study of vitamin D’s role in biological processes such as calcium homeostasis, immune response, and cell proliferation. With CYP24A1 absent, cells display altered responses to vitamin D, offering a unique model for examining its protective roles against diseases like cancer, autoimmune disorders, and cardiovascular conditions. This model is particularly valuable in research settings aimed at elucidating the relationship between vitamin D status and chronic diseases.
In terms of scientific importance, CYP24A1 knockout cell lines enable the identification of novel therapeutic pathways by demonstrating how vitamin D modulation influences cellular behavior and disease progression. Their application extends to pharmacological research, where they can be used to screen for medication responses and the effectiveness of vitamin D analogs.
What sets our CYP24A1 Gene Knockout Cell Lines apart from alternatives is their high specificity and reliability, allowing researchers to achieve reproducible results across experiments. Furthermore, our cell lines are produced under stringent quality control measures, ensuring cell viability and functionality, which translates into significant time savings for researchers.
For researchers and clinicians seeking to deepen their understanding of vitamin D in health and disease or to develop innovative therapies, our CYP24A1 Gene Knockout Cell Lines provide an indispensable resource. Our company boasts extensive expertise in genetic engineering and cell line production, making us a trusted partner in advancing biomedical research and therapeutic discovery.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.